Orthopedic implant particle-induced tumor necrosis factor-α production in macrophage-monocyte lineage cells is mediated by nuclear factor of activated T cells

Annals of the New York Academy of Sciences

Volumn 1117, Issue , 2007, Pages 143-150

  Minematsu, Hiroshi ^a   Shin, Mike J ^a   Celil Aydemir, Ayse B ^a   Sung, Wook Seo ^a   Dae, Won Kim ^a   Blaine, Theodore A ^a   Macián, Fernando ^b   Yang, Jay ^a   Lee, Francis Young In ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Macrophage; NFAT; Osteolysis; TNF ; Wear particle

Indexed keywords

CALCINEURIN; NANOPARTICLE; PEPTIDE; PROTEIN INHIBITOR; TITANIUM; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VALYLISOLEUCYLVALYLISOLEUCYLTHREONINE;

ANIMAL CELL; BIOINFORMATICS; CELL LINEAGE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; IMPLANT; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SECRETION;

MURINAE;

EID: 36549087731     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.026     Document Type: Conference Paper

References (14)

1. SCHMALZRIED, T.P. & W.H. HARRIS. 1992. The Harris-Galante porous-coated acetabular component with screw fixation. Radiographic analysis of eighty-three primary hip replacements at a minimum of five years. J. Bone Joint Surg. Am. 74: 1130-1139.
2. BLAINE, T.A. et al. 1996. Increased levels of tumor necrosis factor-alpha and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J. Bone Joint Surg. Am. 78: 1181-1192.
3. SCHWARZ, E.M. et al. 2000. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J. Orthop. Res. 18: 472-480.
4. SOLOVIEV, A. et al. 2002. The role of p105 protein in NFkappaB activation in ANA-1 murine macrophages following stimulation with titanium particles. J. Orthop. Res. 20: 714-722.
5. SHAW, J.P. et al. 1988. Identification of a putative regulator of early T cell activation genes. Science 241: 202-205.
6. TAKAYANAGI, H. et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3: 889-901.
7. KOGA, T. et al. 2005. NFAT and Osterix cooperatively regulate bone formation. Nat. Med. 11: 880-885.
8. ARAMBURU, J. et al. 1999. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285: 2129-2133.
9. NOGUCHI, H. et al. 2004. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat. Med. 10: 305-309.
10. LIN, Y.Z. et al. 1995. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270: 14255-14258.
11. NARDONE, J. et al. 2004. Bioinformatics for the 'bench biologist': how to find regulatory regions in genomic DNA. Nat. Immunol. 5: 768-774.
12. FALVO, J.V. et al. 2000. Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol. Cell Biol. 20: 2239-2247.
13. TSYTSYKOVA, A.V. & A.E. GOLDFELD. 2002. Inducer-specific enhanceosome formation controls tumor necrosis factor alpha gene expression in T lymphocytes. Mol. Cell Biol. 22: 2620-2631.
14. DIPIETRO, L.A. et al. 1998. MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J. Clin. Invest. 101: 1693-1698.